# ABX-CRO Advanced Pharmaceutical Services GmbH – FDA Inspection, Apr 30, 2025

Source: https://www.keypedia.com/records/fda_inspections/abx-cro-advanced-pharmaceutical-services-gmbh/8a82adf1-fa11-464f-9113-f08f0bd1b29d
Source feed: FDA_Inspections

> FDA inspection 1271008 of ABX-CRO Advanced Pharmaceutical Services GmbH, April 30, 2025. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1271008
- Company Name: ABX-CRO Advanced Pharmaceutical Services GmbH
- Inspection Date: 2025-04-30
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1301802 - 2026-01-23](https://www.keypedia.com/records/fda_inspections/abx-cro-advanced-pharmaceutical-services-gmbh/dbf6194f-e5be-4d90-adf5-0b6bb6a45fb8)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/tawny-l-colling/4ce51467-468c-4271-a98d-4b13c15c0812)

Company: https://www.keypedia.com/companies/abx-cro-advanced-pharmaceutical-services-gmbh/792b1a83-f2f2-4c70-a772-1e82c63e1b6a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c